The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback